TipRanks
SAMSUNG BIOLOGICS Co., Ltd. (KR:207940)
:207940
South Korea Market
207940
SAMSUNG BIOLOGICS Co., Ltd.
RESEARCH TOOLSreports

SAMSUNG BIOLOGICS Co., Ltd. (207940) Income Statement

1 Followers

SAMSUNG BIOLOGICS Co., Ltd. Income Statement

Last quarter (Q2 2026), SAMSUNG BIOLOGICS Co., Ltd.'s total revenue was ₩1.32T, an increase of 2.40% from the same quarter last year. In Q2, SAMSUNG BIOLOGICS Co., Ltd.'s net income was ₩430.70B. See SAMSUNG BIOLOGICS Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 4.56T₩ 3.50T₩ 3.69T₩ 3.00T₩ 1.57T
Gross Profit
₩ 2.48T₩ 1.68T₩ 1.77T₩ 1.44T₩ 784.97B
Operating Expenses
₩ 415.40B₩ 360.20B₩ 657.11B₩ 458.12B₩ 247.66B
Depreciation and Amortization
₩ 633.64B₩ 599.10B₩ 489.78B₩ 308.26B₩ 161.79B
EBITDA
₩ 2.78T₩ 2.03T₩ 1.69T₩ 1.38T₩ 737.78B
Operating Income
₩ 2.07T₩ 1.32T₩ 1.11T₩ 983.63B₩ 537.31B
Other Income/Expenses
₩ 49.41B₩ 63.50B₩ 6.31B₩ 25.40B₩ 23.97B
Pretax Income
₩ 2.12T₩ 1.38T₩ 1.12T₩ 1.01T₩ 561.28B
Net Income
₩ 1.78T₩ 1.08T₩ 857.69B₩ 798.06B₩ 393.59B
Per Share Metrics
Basic EPS
₩ 38.59K₩ 23.40K₩ 18.53K₩ 17.59K₩ 9.05K
Diluted EPS
₩ 38.59K₩ 23.40K₩ 18.53K₩ 17.58K₩ 9.05K
Weighted Average Shares Outstanding
 46.24M 46.29M 46.29M 45.36M 43.49M
Weighted Average Shares Outstanding (Diluted)
 46.24M 46.29M 46.29M 45.40M 43.49M
Currency in KRW

SAMSUNG BIOLOGICS Co., Ltd. Earnings and Revenue History